| STANDARDS AND CRITERIA |
| MASAC Document # |
Board Approved Date |
Title |
|
132 |
3/24/2002 |
Standards and Criteria for the Care of Persons With Congenital Bleeding Disorders |
| TREATMENT RECOMMENDATIONS |
| 179 |
11/04/2007 |
MASAC Recommendation Concerning Prophylaxis |
| 215 |
11/11/2012 |
MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders
(Revised November 2012) |
| 183 |
11/16/2008 |
MASAC STATEMENT REGARDING USE OF HERBAL OR HOMEOPATHIC PRODUCTS TO TREAT VON WILLEBRAND DISEASE |
| 204 |
05/01/2011 |
MASAC RECOMMENDATIONS REGARDING PHYSICAL THERAPY GUIDELINES IN PATIENTS WITH BLEEDING DISORDERS |
| MANAGEMENT ISSUES |
| 115 |
6/9/2001 |
MASAC Recommendations Regarding Central Venous Access Devices Including Ports and Passports |
| 128 |
11/17/2001 |
MASAC Recommendations for Hepatitis A and B Immunization of Individuals with Bleeding Disorders |
| 147 |
11/9/2003 |
TRANSITION GUIDELINES
For People with Bleeding Disorders |
| 162 |
6/4/2005 |
MASAC Recommendations on Use of COX-2 Inhibitors in Persons with Bleeding Disorders
|
| 211 |
6/22/2012 |
MASAC Recommendations Regarding Inhibitor Risk and Recombinant Factor VIII Concentrates
|
| 216 |
5/10/2013 |
MASAC Statement Regarding Inhibitor Risk and Recombinant Factor VIII Concentrates
|
| CLOTTING FACTOR PRODUCTS |
|
31 |
3/30/1993 |
MASAC Statement on Phase IV Post Licensing Studies
|
|
37 |
8/2/1994 |
MASAC Recommendation Concerning Parvovirus Transmission by Clotting Factor Concentrates
|
|
73 |
11/2/1997 |
Recommendations Regarding Blood Safety Policies
|
|
99 |
6/10/2000 |
MASAC Resolution on Creutzfeldt-Jakob Disease, new variant CJD, and Plasma-Derived Coagulation Products
|
| 139 |
3/8/2003 |
MASAC RECOMMENDATIONS ON THE IQPP AND QSEAL PROGRAMS OF THE PLASMA PROTEIN THERAPEUTICS ASSOCIATION
|
| 140 |
3/8/2003 |
MASAC Recommendation on Reporting of Possible West Nile Virus Cases
|
| 157 |
11/7/2004 |
MASAC Resolution on the Thrombogenicity of Bypassing Agents for Management of Hemophilia Complicated by Inhibitors
|
| 158 |
11/7/2004 |
MASAC Recommendations Regarding Exposure to Blood Product Derivatives and Potential Risk of vCJD.
|
| EMERGENCY CARE |
| 113 |
3/4/2001 |
MASAC Recommendations on Improved Access to Emergency Medical Care for Persons with Inherited Bleeding Disorders
|
| 129 |
11/17/2001 |
MASAC Resolution Regarding Emergency Supply of Factor Concentrate |
| 175 |
10/15/2006 |
GUIDELINES FOR EMERGENCY DEPARTMENT MANAGEMENT OF INDIVIDUALS WITH HEMOPHILIA |
| 201 |
01/13/2011 |
MASAC RECOMMENDATION ON USE OF EMERGENCY MEDICAL IDENTIFICATION DEVICES FOR CHILDREN
|
| INFECTIOUS DISEASE COMPLICATIONS |
|
90 |
10/25/1998 |
MASAC Revised Recommendation Regarding Treatment of HCV in HIV Coinfected Individuals with Hemophilia and Other Inherited Bleeding Disorders
|
|
93 |
6/26/1999 |
MASAC Statement on Pregnancy Options for HIV-Discordant Couples
|
|
98 |
6/10/2000 |
MASAC Recommendations on Liver Biopsy in Individuals with Hemophilia
|
| 108 |
11/12/2000 |
MASAC Recommendation Regarding Treatment of AIDS Wasting
|
| 109 |
3/4/2001 |
MASAC Resolution Concerning Participation in AIDS Clinical Trials by HIV-Infected Persons with Bleeding Disorders
|
| 110 |
3/4/2001 |
MASAC Recommendation Concerning CMV Screening of Blood Products for Use in HIV-Positive Individuals with Hemophilia
|
|
119 |
6/9/2001 |
MASAC Recommendation Regarding Post HIV-Exposure Chemoprophylaxis
(see also #123) |
| 121 |
11/17/2001 |
MASAC Recommendations for Immunization of HIV-Infected Individuals |
| 123 |
11/17/2001 |
MASAC Recommendations Regarding Hepatitis B, Hepatitis C and HIV Postexposure Chemoprophylaxis |
| 154 |
11/9/2003 |
MASAC RECOMMENDATIONS REGARDING THE USE OF ANTIRETROVIRAL THERAPY IN THE TREATMENT OF HIV INFECTION
(Revised November 2003)
|
| 213 |
11/11/2012 |
MASAC RECOMMENDATIONS FOR TREATMENT OF CHRONIC HCV INFECTION IN INDIVIDUALS WITH HEMOPHILIA AND OTHER RARE BLEEDING DISORDERS
|
| ORTHOPEDICS AND PHYSICAL THERAPY |
|
102 |
11/12/2000 |
MASAC Recommendation Regarding the Need for Collaborative Effort to Collect Data Regarding Interventions to Prevent Joint Damage Secondary to Hemophilia
|
|
105 |
11/12/2000 |
MASAC Recommendation Regarding Prevention of Cryptosporidiosis in and the Use of Therapeutic Pools by HIV-Infected Persons
|
| 130 |
3/24/2002 |
MASAC Recommendation Regarding the Use of Therapeutic Ultrasound to Aid in Blood Resorption |
| 194 |
06/26/2010 |
MASAC Recommendations Regarding Radionuclide Synovectomy |
| POLICY |
|
28 |
11/22/1992 |
MASAC Statement on Testimony Provided by Physicians and/or Others Associated with the National Hemophilia Foundation
|
|
40 |
8/2/1994 |
MASAC Resolution on Home Care Delivery Systems
|
| 73 |
11/2/1997 |
MASAC RECOMMENDATIONS REGARDING BLOOD SAFETY POLICIES
|
|
94 |
12/21/1999 |
Resolution Regarding Consumer Participation in the National Notification System
|
|
101 |
6/10/2000 |
MASAC Recommendation Regarding Reimbursement for Treatment of Acquired Hemophilia
|
| 111 |
3/4/2001 |
MASAC Resolution Concerning the Development of Comprehensive Outcome Measures
|
|
136 |
11/2/2002 |
MASAC STANDARD ON DISCLOSING CONFLICTS OF INTEREST FOR INDIVIDUALS CONDUCTING CLINICAL RESEARCH ON BLEEDING AND CLOTTING DISORDERS
|
|
138 |
11/2/2002 |
MASAC RESOLUTION ON REIMBURSEMENT FOR INDIVIDUALS RESUMING USE OF RECOMBINANT FACTOR VIII CONCENTRATE
|
| 140 |
3/8/2003 |
MASAC RESOLUTION ON REPORTING OF
POSSIBLE WEST NILE VIRUS CASES
|
| 206 |
11/12/2011 |
MASAC RECOMMENDATIONS REGARDING RARE
COAGULATION FACTOR DISORDERS
|
| 145 |
10/19/2003 |
MASAC RECOMMENDATION ON FUNDING OF THE OFFICE OF CELLULAR AND GENE THERAPIES
|
| 146 |
10/19/2003 |
MASAC Recommendation Regarding Medicaid Inpatient Clotting Factor Replacement Therapy Reimbursement for Hemophilia
|
| 148 |
11/9/2003 |
MASAC Resolution on NHF Educational Program for Fellows |
| 149 |
11/9/2003 |
MASAC Recommendation on the World Health Organization Essential Drug List |
| 152 |
11/9/2003 |
MASAC Recommendations Regarding the Inclusion of Thrombophilia in NHF Research and Educational Efforts |
| 153 |
11/9/2003 |
MASAC Recommendation Concerning Reimbursement for Recombinant Clotting Factor Concentrates |
| 159 |
3/12/2005 |
MASAC Recommendation Regarding Factor Concentrate Prescriptions and Formulary Development and Restrictions |
| 188 |
11/16/2008 |
MASAC Recommendations Regarding Standards of Service for Pharmacy Providers of Clotting Factor Concentrates for Home Use to Patients with Bleeding Disorders |
| 184 |
11/16/2008 |
MASAC CONSENSUS STATEMENT REGARDING THE USE OF FRESH FROZEN PLASMA FOR THE IMMEDIATE REVERSAL OF THE ANTICOAGULANT EFFECTS AND/OR BLEEDING COMPLICATIONS ASSOCIATED WITH ORAL VITAMIN K ANTAGONISTS |
| 207 |
11/12/2011 |
MASAC Recommendations Regarding Non-sterile Alcohol Prep Pads |
| 208 |
6/22/2012 |
MASAC Recommendation on Orphan Drugs |
| 209 |
6/22/2012 |
MASAC Statement on Biosimilars |
| RESEARCH |
|
91 |
2/28/1999 |
MASAC Recommendation Regarding Risk of Germline Transmission in Gene Therapy Trials for Hemophilia |
|
214 |
11/11/2012 |
MASAC Recommendations on the NHF Genotyping Project for Persons with Hemophilia
|
| 111 |
3/4/2001 |
MASAC Resolution Concerning the Development of Comprehensive Outcome Measures
|
| 212 |
11/11/2012 |
MASAC Document Regarding Risks of Gene Therapy Trials for Hemophilia |
|
136 |
11/2/2002 |
MASAC STANDARD ON DISCLOSING CONFLICTS OF INTEREST FOR INDIVIDUALS CONDUCTING CLINICAL RESEARCH ON BLEEDING AND CLOTTING DISORDERS |
|
137 |
11/2/2002 |
MASAC RECOMMENDATIONS FOR CONDUCTING GENE TRANSFER CLINICAL TRIALS IN PERSONS WITH BLEEDING DISORDERS (Revised November 2002) |
| 144 |
10/19/2003 |
MASAC STATEMENT ON THE ROLE AND RESPONSIBILITIES OF THE PRINCIPAL INVESTIGATOR IN BLEEDING DISORDER CLINICAL TRIALS |
| 160 |
3/12/2005 |
MASAC Recommendation on the Need for Long-Term Follow-Up of Hemophilic Dogs in Gene Transfer Studies |
| 161 |
6/4/2005 |
MASAC Resolution on Stem Cell Research for Potential Cure of Bleeding Disorders |
| WOMEN AND BLEEDING DISORDERS |
|
77 |
2/21/1998 |
Recommendations Regarding Neonatal Intracranial Hemorrhage and Postpartum Hemorrhage
|
|
93 |
6/26/1999 |
MASAC Statement on Pregnancy Options for HIV-Discordant Couples
|
| 119 |
6/9/2001 |
MASAC Recommendation Regarding Post HIV-Exposure Chemoprophylaxis |
| 122 |
11/17/2001 |
MASAC Recommendations Concerning the Use of Antiretroviral Drugs During Pregnancy to Prevent Transmission of HIV to the Infant |
| 150 |
11/9/2003 |
MASAC Recommendations on the Use of Blood Products during Pregnancy and Testing for Parvovirus B19 |
|
192 |
11/01/09 |
MASAC Guidelines for Perinatal Management of Women with Bleeding Disorders and Carriers of Hemophilia A and B
|
|
197 |
06/26/10 |
Recommendations Regarding Girls and Women with Inherited Bleeding Disorders
|
| 196 |
06/26/10 |
MASAC Resolution Regarding the Treatment of von Willebrand Disease
|
| 180 |
6/15/08 |
MASAC Endorsement of the NHLBI Consensus Guidelines on the Diagnosis and Treatment of von Willebrand Disease
|